Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma
Clinical trial NCT03788174 · UNKNOWN
Trial details
- NCT number
- NCT03788174
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2019-12-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.